Skip to content
healthcare.dev

Lamotrigine

NDC 0228-1422, Lamotrigine, tablet, film coated, extended release, from Actavis Pharma, Inc..

Product NDC
0228-1422
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200672
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0228-1422 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE100 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
0228-1422-030022814220330 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-1422-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/87beaf22-593d-4170-bb58-332c615ef90d
  • NADAC price for package 00228142203

    GET /v1/drugs/nadac/00228142203

Use it

Look up 0228-1422 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0228-1422 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0228-1422. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.